Hunger after poor sleep, stressful days or low-protein meals often becomes clear through simple tracking
The glucagon arm is the third lever: rather than only reducing energy intake through appetite, glucagon agonism raises energy expenditure and pushes the liver to mobilize stored fat
Why stopping GLP-1 drugs may undo weight loss and heart gains Research shows stopping GLP-1 receptor agonists may reverse gains and raise risks of heart attack or stroke
Proactive Injury Protection BPC-157 strengthens connective tissues before problems develop, making it an excellent preventive treatment
Calcium-dependent lateral organization in phosphatidylinositol 4,5-bisphosphate (PIP2)- and cholesterol-containing monolayers
A poor glycemic control promoted higher levels of inflammatory markers during COVID-19 [130], and an adequate glycemic range (3.910 mmol/L) was associated with a reduction of adverse COVID-19 outcomes, including death [132]